External validation of a US-derived nomogram that predicts individual survival after gastric cancer resection
External validation of a US-derived nomogram that predicts individual survival after gastric cancer resection
复制标题
DOI：
10.1007/s00423-008-0426-z
复制
发表时间：
2009-07-01
影响因子：
2.3
通讯作者：
Tez, Mesut
中科院分区：
文献类型：
--
作者：
Koc, Mahmut;Dizen, Hayrettin;Tez, Mesut
尊敬的先生;虽然胃癌的发病率在西欧正在下降，但该疾病仍然是全世界癌症死亡的第二大常见原因。手术是唯一的治疗方法[1，2]。Kemperor等人建立了一个列线图，该列线图来自于在纽约纪念斯隆-凯特琳癌症中心接受R 0胃癌切除术的1，039例患者。诺模图结合了容易获得的因素：性别，年龄，肿瘤位置，Lauren组织型，组织学阳性和阴性淋巴结的数量，以及浸润深度，这些数据应该在每个进行胃癌手术的机构中可用[3]。
Dear Sir; Although the incidence of gastric carcinoma is declining in Western Europe, the disease remains the second most common cause of cancer death worldwide. Surgery is the only curative treatment [1, 2]. Kattan et al. established a nomogram derived from 1,039 patients who underwent R0 gastric cancer resection at Memorial Sloan-Kettering Cancer Center, NY. The nomogram combines easily accessible factors: sex, age, tumor location, Lauren histotype, number of histologic positive and negative nodes, as well as depth of invasion, data that should be available in every institution performing gastric cancer surgery [3].